<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="gcms/PMC6213187/results/search/country/results.xml">
  <result pre="initiation of hemodialysis (HD) or peritoneal dialysis (PD). In the" exact="United States," post="there has been a 28% reduction in mortality rate"/>
  <result pre="of dialysis patients from 16 countries was identified, mainly from" exact="Japan" post="( n = 8, total patients = 1135) and"/>
  <result pre="n = 8, total patients = 334), followed by the" exact="United States" post="of America (USA) ( n = 7, total patients"/>
  <result pre="America (USA) ( n = 7, total patients = 561)," exact="Italy" post="( n = 4, total patients = 159), France"/>
  <result pre="561), Italy ( n = 4, total patients = 159)," exact="France" post="( n = 4, total patients = 84), Serbia"/>
  <result pre="159), France ( n = 4, total patients = 84)," exact="Serbia" post="( n = 3, total patients = 102), Denmark"/>
  <result pre="84), Serbia ( n = 3, total patients = 102)," exact="Denmark" post="( n = 2, total patients = 250), Turkey"/>
  <result pre="102), Denmark ( n = 2, total patients = 250)," exact="Turkey" post="( n = 2, total patients = 91), Poland"/>
  <result pre="250), Turkey ( n = 2, total patients = 91)," exact="Poland" post="( n = 2, total patients = 61), Australia"/>
  <result pre="91), Poland ( n = 2, total patients = 61)," exact="Australia" post="( n = 2, total patients = 40), Sweden"/>
  <result pre="61), Australia ( n = 2, total patients = 40)," exact="Sweden" post="( n = 1, total patients = 222), Brazil"/>
  <result pre="40), Sweden ( n = 1, total patients = 222)," exact="Brazil" post="( n = 1, total patients = 88), the"/>
  <result pre="Brazil ( n = 1, total patients = 88), the" exact="Netherlands" post="( n = 1, total patients = 32), Austria"/>
  <result pre="the Netherlands ( n = 1, total patients = 32)," exact="Austria" post="( n = 1, total patients = 26), South"/>
  <result pre="32), Austria ( n = 1, total patients = 26)," exact="South Africa" post="( n = 1, total patients = 14), and"/>
  <result pre="Africa ( n = 1, total patients = 14), and" exact="Argentina" post="( n = 1, total patients = 10). When"/>
  <result pre="( n = 7), South America ( n = 2)," exact="Australia" post="( n = 2) and Africa ( n ="/>
  <result pre="EPA + DHA levels in PL reported in studies from" exact="Japan" post="(6.8%) and Sweden (6.5%) were considered moderate, whereas low"/>
  <result pre="levels in PL reported in studies from Japan (6.8%) and" exact="Sweden" post="(6.5%) were considered moderate, whereas low levels of PL"/>
  <result pre="PL EPA + DHA were observed in dialysis patients from" exact="Denmark" post="(5.5–5.7%) and Australia (5.2%). Very low levels of EPA"/>
  <result pre="DHA were observed in dialysis patients from Denmark (5.5–5.7%) and" exact="Australia" post="(5.2%). Very low levels of EPA + DHA in"/>
  <result pre="EPA + DHA in PL were reported in studies from" exact="Serbia" post="(3.0–3.3%) and USA (~2.8%). High levels of erythrocyte EPA"/>
  <result pre="of erythrocyte EPA + DHA were reported in studies from" exact="Japan" post="(9.7%) and Korea (&amp;gt;8%), whereas studies from Italy and"/>
  <result pre="studies from Japan (9.7%) and Korea (&amp;gt;8%), whereas studies from" exact="Italy" post="and France reported low and moderate levels of EPA"/>
  <result pre="Japan (9.7%) and Korea (&amp;gt;8%), whereas studies from Italy and" exact="France" post="reported low and moderate levels of EPA + DHA"/>
  <result pre="EPA + DHA were observed in studies from USA (3.4–5.0%)," exact="Serbia" post="(2.2–4.5%), and South Africa (3.9%). 3.3. Blood FA Status"/>
  <result pre="were observed in studies from USA (3.4–5.0%), Serbia (2.2–4.5%), and" exact="South Africa" post="(3.9%). 3.3. Blood FA Status of Dialysis Patients Compared"/>
  <result pre="[ 20]. Healthy adults from countries on the Sea of" exact="Japan" post="(Japan and South Korea) and Scandinavia (Denmark and Sweden)"/>
  <result pre="in healthy adults from North and South America, Africa, and" exact="Serbia" post="[ 20]. This is likely due to the dietary"/>
  <result pre="observed higher total serum OA proportions in studies originating from" exact="Italy" post="[ 67] and Poland [ 55], which may be"/>
  <result pre="OA proportions in studies originating from Italy [ 67] and" exact="Poland" post="[ 55], which may be related to higher dietary"/>
  <result pre="authors declare no conflict of interest. References References 1. collab:" exact="United States" post="Renal Data System 2017 USRDS Annual Data Report: Epidemiology"/>
  <result pre="USRDS Annual Data Report: Epidemiology of Kidney Disease in the" exact="United States" post="National Institutes of Health, National Institute of Diabetes and"/>
  <result pre="N/A INT PL GC-FID de Gomez Dumm (2001) [ 34]" exact="Argentina" post="10 33.3 6/4 HD 60 PC Total plasma GLC-FID"/>
  <result pre="60 PC Total plasma GLC-FID de Mattos (2017) [ 35]" exact="Brazil" post="88 52.0 57/31 HD 54.4 INT Total serum GC"/>
  <result pre="HD 54.4 INT Total serum GC Delarue (2008) [ 36]" exact="France" post="8 62.0 6/2 HD ≥ 6 INT TAG GC"/>
  <result pre="HD ≥ 6 INT TAG GC Delmas-Beauvieux (1995) [ 37]" exact="France" post="40 58.1 19/21 HD ≥ 6 CS Erythrocyte GC"/>
  <result pre="HD ≥ 6 CS Erythrocyte GC Dessi (2014) [ 38]" exact="Italy" post="99 69.3 59/40 HD 65.8 CS PL, Erythrocyte GC-MS"/>
  <result pre="HD 65.8 CS PL, Erythrocyte GC-MS Esaki (2017) [ 39]" exact="Japan" post="10 74.7 7/3 HD 100.8 INT Total serum N/A"/>
  <result pre="11/9 HD 96.0 CS PL GC Girelli (1992) [ 43]" exact="Italy" post="32 61.9 16/16 HD, PD 42.0 CS Erythrocyte GC"/>
  <result pre="HD, PD 42.0 CS Erythrocyte GC Hamazaki (1984) [ 44]" exact="Japan" post="12 N/A 3/9 HD 31.0 INT Total plasma GC"/>
  <result pre="31.0 INT Total plasma GC Hamazaki (2011) [ 25, 45]" exact="Japan" post="176 64.1 96/80 HD 92.4 PC Erythrocyte GC Holler"/>
  <result pre="96/80 HD 92.4 PC Erythrocyte GC Holler (1995) [ 46]" exact="Austria" post="26 48.2 14/12 PD N/A CS Total serum GC"/>
  <result pre="N/A CS Total serum GC Huang (2012) [ 27, 47]" exact="Sweden" post="222 57.0 135/87 HD, PD 12.0 PC PL GLC"/>
  <result pre="HD ≥ 6 INT Erythrocyte GC Madsen (2011) [ 51]" exact="Denmark" post="44 63 29/15 HD 30.0 CS PL GC-FID Marangoni"/>
  <result pre="29/15 HD 30.0 CS PL GC-FID Marangoni (1992) [ 52]" exact="Italy" post="18 48.7 10/8 HD ≥ 6 CS TAG, CE,"/>
  <result pre="6 CS TAG, CE, PL GLC Nakamura (2008) [ 53]" exact="Japan" post="17 57.0 N/A HD N/A CS Total plasma GC"/>
  <result pre="HD, PD 49.0 CS Erythrocyte GC Pazda (2017) [ 55]" exact="Poland" post="28 50.7 15/13 PD N/A CS Total serum GC-FID"/>
  <result pre="HD N/A INT Total plasma GC Perunicic-Pekovic (2007) [ 57]" exact="Serbia" post="35 N/A N/A HD N/A INT Erythrocyte GLC Peuchant"/>
  <result pre="N/A HD N/A INT Erythrocyte GLC Peuchant (1988) [ 58]" exact="France" post="22 N/A N/A HD 78.0 CS Erythrocyte GC-FID Peuchant"/>
  <result pre="N/A HD 78.0 CS Erythrocyte GC-FID Peuchant (1994) [ 59]" exact="France" post="14 51.0 5/9 HD 96.0 CS Total plasma, erythrocyte"/>
  <result pre="96.0 CS Total plasma, erythrocyte GLC Ristic (2006) [ 60]" exact="Serbia" post="37 52.0 21/16 HD 72.0 CS PL, erythrocyte GC"/>
  <result pre="HD 72.0 CS PL, erythrocyte GC Ristic-Medic (2014) [ 61]" exact="Serbia" post="30 55.0 18/12 HD 57.1 INT PL GC Sertoglu"/>
  <result pre="18/12 HD 57.1 INT PL GC Sertoglu (2014) [ 62]" exact="Turkey" post="40 58.0 21/19 HD N/A CS Total plasma, erythrocyte"/>
  <result pre="N/A CS Total plasma, erythrocyte GC-FID Shoji (2013) [ 63]" exact="Japan" post="517 61.0 325/ 192 HD 110.4 PC Total serum"/>
  <result pre="HD 110.4 PC Total serum GC Sikorska-Wisiewska (2017) [ 64]" exact="Poland" post="33 55.8 18/15 HD, PD 12.2 CS Total serum"/>
  <result pre="10/21 HD 46.1 CS Erythrocyte GC Svensson (2006) [ 66]" exact="Denmark" post="206 67.0 133/73 HD 44.0 INT PL GC-FID Taccone-Galluci"/>
  <result pre="133/73 HD 44.0 INT PL GC-FID Taccone-Galluci (1989) [ 67]" exact="Italy" post="10 N/A 6/4 HD 27.0 CS Total serum GC"/>
  <result pre="CS TAG &amp;amp; CE, PL GLC Tsuzuki (2000) [ 69]" exact="Japan" post="20 55.6 11/9 HD 80.4 CS Erythrocyte GC-MS Umemoto"/>
  <result pre="11/9 HD 80.4 CS Erythrocyte GC-MS Umemoto (2016) [ 70]" exact="Japan" post="367 66.0 237/130 HD 109.2 CS Total serum GC"/>
  <result pre="HD 109.2 CS Total serum GC Westhuyzen (2003) [ 71]" exact="Australia" post="12 69.2 7/5 HD N/A INT Erythrocyte GC-FID Yerlikaya"/>
  <result pre="7/5 HD N/A INT Erythrocyte GC-FID Yerlikaya (2011) [ 72]" exact="Turkey" post="51 47.8 21/30 PD 65.4 CS Total plasma GC-MS"/>
  <result pre="PD 65.4 CS Total plasma GC-MS Yoshimoto-Furuie (1999) [ 73]" exact="Japan" post="16 52.7 6/10 HD 62.4 INT TAG, CE, PL"/>
  <result pre="62.4 INT TAG, CE, PL GC Zabel (2010) [ 74]" exact="Australia" post="28 61.0 14/14 HD 19.5 INT PL GC Abbreviations:"/>
  <result pre="PC, prospective cohort; PD, peritoneal dialysis; PL, phospholipid; S. Africa," exact="South Africa;" post="TAG, triacylglycerol; USA, United States of America. nutrients-10-01353-t002_Table 2"/>
  <result pre="dialysis; PL, phospholipid; S. Africa, South Africa; TAG, triacylglycerol; USA," exact="United States" post="of America. nutrients-10-01353-t002_Table 2 Table 2 Blood fatty acid"/>
  <result pre="PUFA n-6/ n-3 Total Serum/Plasma Asia Hamazaki (1984) [ 44]" exact="Japan" post="22.7 5.0 3.5 22.6 31.5 3.8 1.1 1.2 1.9"/>
  <result pre="22.6 31.5 3.8 1.1 1.2 1.9 Nakamura (2008) [ 53]" exact="Japan" post="30.1 5.2 0.1 0.8 2.3 0.7 4.1 Esaki (2017)"/>
  <result pre="5.2 0.1 0.8 2.3 0.7 4.1 Esaki (2017) [ 39]" exact="Japan" post="21.9 5.9 25.7 27.4 5.8 1.0 1.1 2.9 Shoji"/>
  <result pre="27.4 5.8 1.0 1.1 2.9 Shoji (2013) a,b [ 63]" exact="Japan" post="139 53 100 Umemoto (2016) a,b [ 70] Japan"/>
  <result pre="63] Japan 139 53 100 Umemoto (2016) a,b [ 70]" exact="Japan" post="149 173 60 100 165 Yerlikaya (2011) [ 72]"/>
  <result pre="Japan 149 173 60 100 165 Yerlikaya (2011) [ 72]" exact="Turkey" post="0.7 21.6 8.1 34.5 1.5 9.2 27.5 23.7 4.6"/>
  <result pre="0.7 0.9 2.6 38.0 19.5 Sertoglu (2014) a [ 62]" exact="Turkey" post="48 308 104 26 357 495 115 634 6"/>
  <result pre="115 634 6 15 20 Europe Taccone-Galluci (1989) [ 67]" exact="Italy" post="1.3 21.6 8.0 2.1 29.9 20.6 7.3 0.6 0.6"/>
  <result pre="20.6 7.3 0.6 0.6 0.9 2.6 Peuchant (1994) [ 59]" exact="France" post="1.3 26.0 11.3 22.3 24.2 7.7 0.6 0.9 2.6"/>
  <result pre="22.3 24.2 7.7 0.6 0.9 2.6 Holler (1996) [ 46]" exact="Austria" post="6.1 0.4 Pazda (2017) [ 55] Poland 1.0 23.4"/>
  <result pre="(1996) [ 46] Austria 6.1 0.4 Pazda (2017) [ 55]" exact="Poland" post="1.0 23.4 7.1 32.5 2.8 29.1 32.7 23.2 5.4"/>
  <result pre="29.9 0.3 0.8 0.4 1.5 3.1 Sikorska-Wisiewska (2017) [ 64]" exact="Poland" post="26.3 3.8 4.0 0.2 0.5 1.2 3.4 28.4 3.7"/>
  <result pre="1.3 40.9 South America de Gomez Dumm (2001) [ 34]" exact="Argentina" post="19.4 6.4 3.1 24.3 31.9 7.5 0.9 0.6 0.6"/>
  <result pre="7.5 0.9 0.6 0.6 1.4 de Mattos (2017) [ 35]" exact="Brazil" post="5.6 0.7 0.6 0.6 Triacylglycerol Asia Yoshimoto-Furuie (1999) ["/>
  <result pre="5.6 0.7 0.6 0.6 Triacylglycerol Asia Yoshimoto-Furuie (1999) [ 73]" exact="Japan" post="23.6 1.6 2.1 1.2 3.8 Europe Marangoni (1992) ["/>
  <result pre="23.6 1.6 2.1 1.2 3.8 Europe Marangoni (1992) [ 52]" exact="Italy" post="31.0 5.0 4.0 45.0 12.0 1.0 Delarue (2008) a"/>
  <result pre="5.0 4.0 45.0 12.0 1.0 Delarue (2008) a [ 36]" exact="France" post="8 10 North America Talwalker (1980) [ 68] USA"/>
  <result pre="38.8 0.8 0.9 Cholesteryl Esters Asia Yoshimoto-Furuie (1999) [ 73]" exact="Japan" post="51.0 6.0 0.6 2.9 1.7 Europe Marangoni (1992) ["/>
  <result pre="51.0 6.0 0.6 2.9 1.7 Europe Marangoni (1992) [ 52]" exact="Italy" post="15.0 2.0 5.0 26.0 45.0 6.0 North America Talwalker"/>
  <result pre="0 0 0 39.3 Phospholipids Asia Yoshimoto-Furuie (1999) [ 73]" exact="Japan" post="23.1 9.1 0.3 0.4 3.1 1.1 7.6 Australia Zabel"/>
  <result pre="[ 73] Japan 23.1 9.1 0.3 0.4 3.1 1.1 7.6" exact="Australia" post="Zabel (2010) [ 74] Australia 10.3 1.1 4.1 Europe"/>
  <result pre="0.3 0.4 3.1 1.1 7.6 Australia Zabel (2010) [ 74]" exact="Australia" post="10.3 1.1 4.1 Europe Marangoni (1992) [ 52] Italy"/>
  <result pre="74] Australia 10.3 1.1 4.1 Europe Marangoni (1992) [ 52]" exact="Italy" post="37.0 15.0 1.0 13.0 13.0 8.0 Dessi (2014) a"/>
  <result pre="15.0 1.0 13.0 13.0 8.0 Dessi (2014) a [ 38]" exact="Italy" post="408 133 5 9 49 de Fijter (1995) ["/>
  <result pre="Fijter (1995) [ 33] NL 4.3 Svensson (2006) [ 66]" exact="Denmark" post="1.5 4.0 Madsen (2011) [ 51] Denmark 9.7 1.6"/>
  <result pre="(2006) [ 66] Denmark 1.5 4.0 Madsen (2011) [ 51]" exact="Denmark" post="9.7 1.6 1.1 4.1 Ristic (2006) b [ 60]"/>
  <result pre="Denmark 9.7 1.6 1.1 4.1 Ristic (2006) b [ 60]" exact="Serbia" post="28.1 15.7 43.8 0.4 13.1 13.5 25.5 11.1 0.4"/>
  <result pre="39.0 0.3 0.5 3.0 3.8 9.6 Ristic-Medic (2014) [ 61]" exact="Serbia" post="25.3 16.4 41.8 0.4 13.8 14.6 24.5 11.6 0.6"/>
  <result pre="0.5 2.8 3.5 42.7 11.3 Huang (2012) [ 27, 47]" exact="Sweden" post="30.4 14.5 0.5 13.7 19.7 9.2 0.3 1.6 1.2"/>
  <result pre="19.2 13.5 0.4 2.4 Erythrocytes Asia Tsuzuki (2000) [ 69]" exact="Japan" post="54.0 19.2 8.5 1.6 1.2 4.9 26.8 Hamazaki (2011)"/>
  <result pre="19.2 8.5 1.6 1.2 4.9 26.8 Hamazaki (2011) [ 45]" exact="Japan" post="26.8 15.0 0.4 13.4 9.1 11.6 2.0 2.5 7.7"/>
  <result pre="6.7 8.1 10.6 35.2 2.8 Sertoglu (2014) a [ 62]" exact="Turkey" post="33 22 51 8 30 35 42 83 3"/>
  <result pre="22 51 8 30 35 42 83 3 5 6" exact="Australia" post="Westhuyzen (2003) [ 71] Australia 22.8 16.9 43.8 15.5"/>
  <result pre="42 83 3 5 6 Australia Westhuyzen (2003) [ 71]" exact="Australia" post="22.8 16.9 43.8 15.5 19.5 8.6 16.7 3.3 0.8"/>
  <result pre="16.7 3.3 0.8 7.3 36.7 Europe Girelli (1992) [ 43]" exact="Italy" post="21.5 16.7 44.4 15.5 16.0 8.4 23.5 6.8 39.3"/>
  <result pre="17.9 8.4 19.8 6.4 35.4 Dessi (2014) a [ 38]" exact="Italy" post="117 145 0.2 3 45 Peuchant (1988) [ 58]"/>
  <result pre="Italy 117 145 0.2 3 45 Peuchant (1988) [ 58]" exact="France" post="0.8 29.4 23.0 13.4 7.9 11.7 2.1 0.5 3.2"/>
  <result pre="13.4 7.9 11.7 2.1 0.5 3.2 Peuchant (1994) [ 59]" exact="France" post="0.8 25.7 22.6 13.4 9.5 13.8 2.7 2.7 4.1"/>
  <result pre="13.4 9.5 13.8 2.7 2.7 4.1 Delmas-Beauvieux (1995) [ 37]" exact="France" post="12.5 11.9 2.3 1.6 4.8 Ristic (2006) [ 60]"/>
  <result pre="France 12.5 11.9 2.3 1.6 4.8 Ristic (2006) [ 60]" exact="Serbia" post="21.6 19.3 40.9 17.9 17.9 14.8 15.3 3.5 34.9"/>
  <result pre="34.9 0.2 1.2 4.3 6.0 5.9 Perunicic-Pekovic (2007) [ 57]" exact="Serbia" post="7.4 0.2 0.6 2.0 Africa Koorts (2002) [ 49]"/>
  <result pre="Serbia 7.4 0.2 0.6 2.0 Africa Koorts (2002) [ 49]" exact="South Africa" post="0.3 22.3 17.4 45.9 0.2 13.3 16.9 10.4 14.8"/>
  <result pre="Netherlands; PUFA, polyunsaturated fatty acid; SFA, saturated fatty acid; USA," exact="United States" post="of America. Fatty acid abbreviations: 14:0, myristic acid; 16:0,"/>
  <result pre="4.69%): 2.48 (0.88–6.95), p = 0.085 Hamazaki, 2011 [ 45]" exact="Japan" post="176 92.4 5 Erythrocyte DHA HR (95% CI) for"/>
  <result pre="(&amp;gt;8.1%) vs. T1 (&amp;lt;7.2%): 0.43 (0.21–0.88) Huang, 2012 [ 47]" exact="Sweden" post="222 12 1.5 PL LA, ALA, MA LC n-3"/>
  <result pre="(1.27–3.07%): 0.20 (0.08–0.51), p = 0.001 Shoji, 2013 [ 63]" exact="Japan" post="517 110.4 5 Total serum (EPA + DHA)/AA ratio"/>
  <result pre="(1.54–2.03): 1.92 (1.25–2.95), p = 0.005 Terashima, 2014 [ 25]" exact="Japan" post="176 92.4 10 Erythrocyte DHA, OA HR (95% CI)"/>
 </snippets>
</snippetsTree>
